From Ithaca to Hawaii to Ecuador, students in the Robert S. Harrison College Scholars Program in the College of Arts & Sciences took advantage of the summer as a time to explore their research interests.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
The size, strength and makeup of people’s social networks are key indicators of how they will respond to the health consequences of an environmental disaster, according to a new Cornell study that focused on the Flint, Michigan water crisis.
A new study reveals that beyond providing a convenient way to store DNA in a tight space, the 3D organization of noncoding gene regulators in chromatin contributes to the control of key cell identity programs in early embryonic development.
In a significant move to fight COVID-19 and other contagious pathogens in health care settings, the U.S. Environmental Protection Agency (EPA) has granted Sterifre Medical, Inc. registration to begin commercial deployment of the company’s novel, automated device disinfectant system.
The Cornell High Energy Synchrotron Source (CHESS) is set to host the Pan American Light Sources for Agriculture conference (PALSA) July 11-14. Registration is still open.
An interdisciplinary Cornell research team has developed a new surgical technique that blocks the spread of focal epileptic seizures in the brain by making precise incisions with femtosecond laser pulses.
Current methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood, which has important implications for determining how harmful they could be to a host, according to a new report.
Ekta Khurana, associate professor of physiology and biophysics at Weill Cornell Medicine, has received a three-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become resistant to hormone-blocking therapy.
The bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to researchers at Weill Cornell Medicine, a discovery that opens up a new line of research on spinal disorders.